Read + Share
Giese-Kim N, Wu M, Dehghan M, Sceats LA, et al. Home Infliximab Infusions Are Associated With Suboptimal Outcomes Without Cost
Savings in Inflammatory Bowel Diseases. Am J Gastroenterol 2020;115:1698-1706.
PMID: 32701731
|
 |
|
Giese-Kim N, Wu M, Dehghan M, Sceats LA, et al. Home Infliximab Infusions Are Associated With Suboptimal Outcomes Without Cost
Savings in Inflammatory Bowel Diseases. Am J Gastroenterol 2020;115:1698-1706.
PMID: 32701731
|
|
|
|